Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

TNYATenaya Therapeutics, Inc.

Nasdaq · CIK 0001858848
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts203

Identity from submissions API

NameTenaya Therapeutics, Inc.
CIK0001858848
TickersTNYA
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN813789973
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone415-865-2066
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
171 OYSTER POINT BLVD., SUITE 500
SOUTH SAN FRANCISCO
CA
94080
CA
Mailing address
171 OYSTER POINT BLVD., SUITE 500
SOUTH SAN FRANCISCO
CA
94080
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

356 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-18 4 4 0001193125-26-467470 5317
2026-11-18 4 4 0001193125-26-467468 5322
2026-11-16 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001193125-26-463722 005-92757 261562282 34 21175
2026-11-04 10-Q 10-Q 0001193125-26-447354 001-40656 261522705 34 10019024 1 1
2026-11-04 8-K 8-K 2.02,9.01 0001193125-26-447273 001-40656 261522378 34 362863 1 1
2026-10-23 DEFA14A DEFA14A 0001193125-26-430642 001-40656 261482957 34 4260701
2026-10-23 DEF 14A DEF 14A 0001193125-26-430591 001-40656 261482790 34 13428225 1 1
2026-10-13 PRE 14A PRE 14A 0001193125-26-420540 001-40656 261457363 34 13308335 1 1
2026-09-11 4 4 0001193125-26-389563 8235
2026-09-11 4 4 0001193125-26-389561 8245
2026-08-24 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-100403 005-92757 261311841 34 18165
2026-08-17 4 4 0001193125-26-354518 11214
2026-08-17 4 4 0001193125-26-354517 11358
2026-08-17 144 xsl144X01/primary_doc.xml 0001193125-26-354513 001-40656 261288225 33 4388
2026-08-17 144 xsl144X01/primary_doc.xml 0001193125-26-354511 001-40656 261288224 33 4353
2026-08-05 S-8 S-8 0001193125-26-335231 333-298011 261244007 33 827860 1 1
2026-08-05 10-Q 10-Q 0001193125-26-335140 001-40656 261243737 34 9591677 1 1
2026-08-05 8-K 8-K 2.02,9.01 0001193125-26-335098 001-40656 261243560 34 372189 1 1
2026-07-14 3 3 0001193125-26-303682 12455
2026-07-14 4 4 0001193125-26-303681 5761
2026-07-02 8-K 8-K 1.02 0001193125-26-294879 001-40656 261152671 34 153807 1 1
2026-06-29 8-K 8-K 5.02,7.01,9.01 0001193125-26-286957 001-40656 261131533 34 333911 1 1
2026-05-29 4 4 0001193125-26-249135 5715
2026-05-29 4 4 0001193125-26-249132 5710
2026-05-29 4 4 0001193125-26-249131 5693
2026-05-29 4 4 0001193125-26-249116 5707
2026-05-29 4 4 0001193125-26-249114 5656
2026-05-29 4 4 0001193125-26-249113 5685
2026-05-29 4 4 0001193125-26-249052 5658
2026-05-29 8-K 8-K 5.02,5.07,9.01 0001193125-26-248680 001-40656 261045848 34 433763 1 1
2026-05-19 4 4 0001193125-26-231324 5143
2026-05-19 4 4 0001193125-26-231323 5154
2026-05-19 4 4 0001193125-26-231315 5140
2026-05-06 10-Q 10-Q 0001193125-26-209084 001-40656 26948874 34 8852851 1 1
2026-05-06 8-K 8-K 2.02,9.01 0001193125-26-208975 001-40656 26948503 34 315887 1 1
2026-04-16 ARS ARS 0001193125-26-158101 001-40656 26865895 34 884349
2026-04-16 DEFA14A DEFA14A 0001193125-26-158096 001-40656 26865888 34 1862341
2026-04-16 DEF 14A DEF 14A 0001193125-26-158079 001-40656 26865849 34 6405506 1 1
2026-03-11 10-K 10-K 0001193125-26-102252 001-40656 26743782 34 11888427 1 1
2026-03-11 8-K 8-K 2.02,9.01 0001193125-26-102170 001-40656 26743495 34 362433 1 1
2026-03-05 8-K 8-K 1.01 0001193125-26-092654 001-40656 26724300 34 166099 1 1
2026-02-26 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-26-076892 005-92757 26689300 34 27804
2026-02-26 4 4 0001193125-26-076814 25277
2026-02-25 144 xsl144X01/primary_doc.xml 0001178937-26-000013 001-40656 26680025 33 9849
2026-02-25 144 xsl144X01/primary_doc.xml 0001178937-26-000012 001-40656 26680007 33 9721
2026-02-24 4 4 0001193125-26-067007 25228
2026-02-20 144 xsl144X01/primary_doc.xml 0001178937-26-000009 001-40656 26661441 33 6299
2026-02-20 144 xsl144X01/primary_doc.xml 0001178937-26-000008 001-40656 26661436 33 6272
2026-02-17 4 4 0001193125-26-055445 9221
2026-02-17 4 4 0001193125-26-055442 9227
2026-02-17 4 4 0001193125-26-055439 9377
2026-02-17 144 xsl144X01/primary_doc.xml 0001193125-26-055437 001-40656 26644542 33 4388
2026-02-17 144 xsl144X01/primary_doc.xml 0001193125-26-055434 001-40656 26644536 33 4354
2026-02-12 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-26-049218 005-92757 26628169 34 164124
2026-02-12 4 4 0001193125-26-049028 25454
2026-02-11 144 xsl144X01/primary_doc.xml 0001178937-26-000007 001-40656 26622364 33 5117
2026-02-11 144 xsl144X01/primary_doc.xml 0001178937-26-000006 001-40656 26622342 33 5146
2026-02-10 144 xsl144X01/primary_doc.xml 0001178937-26-000005 001-40656 26617361 33 5550
2026-02-10 144 xsl144X01/primary_doc.xml 0001178937-26-000004 001-40656 26617120 33 5580
2026-02-05 4 4 0001193125-26-039768 8049
2026-02-05 4 4 0001193125-26-039763 8062
2026-02-05 4 4 0001193125-26-039760 8052
2026-02-03 S-8 S-8 0001193125-26-035501 333-293163 26592859 33 388372 1 1
2026-01-30 8-K 8-K 3.01,5.02,9.01 0001193125-26-032017 001-40656 26584358 34 743339 1 1
2026-01-02 8-K 8-K 5.02 0001193125-26-001065 001-40656 26503132 34 155315 1 1
2025-12-17 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-25-322770 005-92757 251579477 34 22083
2025-12-12 8-K 8-K 1.01,7.01,9.01 0001193125-25-317642 001-40656 251568547 34 608587 1 1
2025-12-12 424B5 424B5 0001193125-25-317609 333-286005 251568362 33 634746
2025-12-11 424B5 424B5 0001193125-25-316104 333-286005 251565522 33 658133
2025-12-11 8-K 8-K 7.01,8.01,9.01 0001193125-25-315951 001-40656 251565113 34 238936 1 1
2025-11-17 4 4 0001193125-25-284999 5000
2025-11-17 4 4 0001193125-25-284997 5014
2025-11-17 4 4 0001193125-25-284996 5004
2025-11-10 10-Q 10-Q 0001193125-25-273239 001-40656 251464308 34 9192046 1 1
2025-11-10 8-K 8-K 2.02,9.01 0001193125-25-273230 001-40656 251464295 34 356439 1 1
2025-11-07 8-K 8-K 8.01 0001193125-25-272423 001-40656 251463005 34 163409 1 1
2025-09-10 UPLOAD filename1.pdf 0000000000-25-009790 001-40656 39710
2025-09-04 CORRESP filename1.htm 0001858848-25-000007 81853
2025-08-26 UPLOAD filename1.pdf 0000000000-25-009101 001-40656 44329
2025-08-18 4 4 0000950170-25-109915 9213
2025-08-18 4 4 0001868494-25-000006 9366
2025-08-18 4 4 0001667937-25-000006 9222
2025-08-18 144 xsl144X01/primary_doc.xml 0001868494-25-000005 001-40656 251229449 33 4355
2025-08-18 144 xsl144X01/primary_doc.xml 0001667937-25-000005 001-40656 251229448 33 4390
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-003594 005-92757 251216134 34 10251
2025-08-06 10-Q 10-Q 0000950170-25-104182 001-40656 251190413 34 8879257 1 1
2025-08-06 8-K 8-K 2.02,9.01 0000950170-25-104164 001-40656 251190294 34 351122 1 1
2025-07-31 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-003291 005-92757 251172223 34 13982
2025-07-16 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-002515 005-92757 251128461 34 10814
2025-05-30 4 4 0000950170-25-079950 5521
2025-05-30 4 4 0000950170-25-079949 5520
2025-05-30 4 4 0000950170-25-079948 5500
2025-05-30 4 4 0000950170-25-079947 5542
2025-05-30 4 4 0000950170-25-079946 5528
2025-05-30 4 4 0000950170-25-079944 5549
2025-05-30 4 4 0000950170-25-079943 5511
2025-05-30 4 4 0000950170-25-079941 5498
2025-05-30 8-K 8-K 5.07 0000950170-25-079773 001-40656 251011525 34 169676 1 1
2025-05-16 4 4 0000950170-25-073825 5001
2025-05-16 4 4 0000950170-25-073824 5016
2025-05-16 4 4 0000950170-25-073823 5005
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-002356 005-92757 25949343 34 8690
2025-05-14 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-25-071441 005-92757 25945835 34 21950
2025-05-07 10-Q 10-Q 0000950170-25-065741 001-40656 25921862 34 8069473 1 1
2025-05-07 8-K 8-K 2.02,9.01 0000950170-25-065703 001-40656 25921669 34 312017 1 1
2025-05-07 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-002134 005-92757 25919604 34 15697
2025-04-18 8-K 8-K 3.01 0000950170-25-055927 001-40656 25850854 34 166422 1 1
2025-04-17 ARS ARS 0001193125-25-084338 001-40656 25847447 34 3413849
2025-04-17 DEFA14A DEFA14A 0001193125-25-084321 001-40656 25847359 34 191198
2025-04-17 DEF 14A DEF 14A 0001193125-25-084313 001-40656 25847292 34 667144
2025-03-31 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000905 333-286005 25796324 33 1780
2025-03-28 8-K 8-K 2.05 0001193125-25-067071 001-40656 25786032 34 154375 1 1
2025-03-27 CORRESP filename1.htm 0001193125-25-065580 16831
2025-03-26 UPLOAD filename1.pdf 0000000000-25-003233 333-286005 40121
2025-03-21 S-3 S-3 0001193125-25-060227 333-286005 25760595 33 1015815
2025-03-10 4 4 0000950170-25-036774 9228
2025-03-10 4 4 0000950170-25-036772 9213
2025-03-10 4 4 0000950170-25-036770 7385
2025-03-10 144 xsl144X01/primary_doc.xml 0000950170-25-036768 001-40656 25725654 33 4361
2025-03-10 144 xsl144X01/primary_doc.xml 0000950170-25-036767 001-40656 25725651 33 4394
2025-03-10 10-K 10-K 0000950170-25-036329 001-40656 25723985 34 12254134 1 1
2025-03-10 8-K 8-K 2.02,9.01 0000950170-25-036296 001-40656 25723840 34 341471 1 1
2025-03-07 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000919574-25-001872 005-92757 25721853 34 20691
2025-03-07 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-25-035821 005-92757 25721792 34 29389
2025-03-07 4 4 0000950170-25-035789 23133
2025-03-07 4 4 0000950170-25-035788 14203
2025-03-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000019617-25-000297 005-92757 25714047 34 6809
2025-03-04 8-K 8-K 1.01,7.01,8.01,9.01 0001193125-25-045628 001-40656 25705020 34 774289 1 1
2025-03-04 424B5 424B5 0001193125-25-045610 333-266741 25704764 33 662026
2025-03-03 424B5 424B5 0001193125-25-044134 333-266741 25698147 33 703104
2025-03-03 424B3 424B3 0001193125-25-044098 333-266741 25697717 33 51480
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-004301 005-92757 25631804 34 17156
2025-02-10 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000019617-25-000183 005-92757 25604768 34 6769
2025-02-07 3 3 0000950170-25-016584 25044
2025-02-07 4 4 0000950170-25-016582 24430
2025-02-07 S-8 S-8 0000950170-25-016405 333-284784 25602688 33 258373
2025-02-07 8-K 8-K 5.02 0000950170-25-016378 001-40656 25602508 34 172961 1 1
2025-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-001248 005-92757 25592240 34 11806
2025-01-28 4 4 0000950170-25-010075 29178
2025-01-28 8-K 8-K 5.02 0000950170-25-009946 001-40656 25565629 34 167840 1 1
2024-12-17 8-K 8-K 7.01,8.01,9.01 0001193125-24-280112 001-40656 241553678 34 7017356 1 1
2024-12-17 8-K 8-K 5.02 0001193125-24-280092 001-40656 241553652 34 147845 1 1
2024-11-18 4 4 0000950170-24-128200 5024
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-119298 005-92757 241464730 34 91095
2024-11-14 SC 13G/A tnya13gasep24.txt 0000080255-24-001465 005-92757 34 6728
2024-11-06 10-Q 10-Q 0000950170-24-122359 001-40656 241431345 34 8239184 1 1
2024-11-06 8-K 8-K 2.02,9.01 0000950170-24-122342 001-40656 241431215 34 302822 1 1
2024-10-21 4 4 0000950170-24-116065 5522
2024-10-21 4 4 0000950170-24-116064 5530
2024-10-21 4 4 0000950170-24-116063 5523
2024-10-21 4 4 0000950170-24-116062 5551
2024-10-21 4 4 0000950170-24-116061 5500
2024-10-21 4 4 0000950170-24-116060 5513
2024-10-21 4 4 0000950170-24-116059 5544
2024-10-21 4 4 0000950170-24-116058 5502
2024-09-17 S-8 S-8 0000950170-24-107007 333-282161 241302520 33 207657
2024-09-16 8-K 8-K 5.02,9.01 0000950170-24-106817 001-40656 241301073 34 677177 1 1
2024-08-19 4 4 0000950170-24-098810 11670
2024-08-19 3 3 0000950170-24-098807 18188
2024-08-16 4 4 0000950170-24-098235 7340
2024-08-16 4 4 0000950170-24-098234 7195
2024-08-16 144 xsl144X01/primary_doc.xml 0000950170-24-098232 001-40656 241218025 33 4362
2024-08-16 144 xsl144X01/primary_doc.xml 0000950170-24-098231 001-40656 241218023 33 4395
2024-08-08 10-Q 10-Q 0000950170-24-094059 001-40656 241188803 34 6909142 1 1
2024-08-08 8-K 8-K 2.02,5.02,9.01 0000950170-24-093991 001-40656 241188523 34 316784 1 1
2024-07-25 8-K 8-K 5.02 0001193125-24-184817 001-40656 241141997 34 148653 1 1
2024-06-27 8-K 8-K 5.02 0000950170-24-078585 001-40656 241080325 34 158468 1 1
2024-05-31 8-K 8-K 5.07 0000950170-24-067318 001-40656 241009843 34 179518 1 1
2024-05-14 10-Q 10-Q 0000950170-24-059576 001-40656 24944556 34 6041737 1 1
2024-05-14 8-K 8-K 2.02,2.05,9.01 0000950170-24-059539 001-40656 24944376 34 296727 1 1
2024-04-17 ARS ARS 0001193125-24-099213 001-40656 24851805 34 816189
2024-04-17 DEFA14A DEFA14A 0001193125-24-099115 001-40656 24851290 34 589724
2024-04-17 DEF 14A DEF 14A 0001193125-24-099107 001-40656 24851255 34 965413
2024-03-18 10-K 10-K 0000950170-24-032828 001-40656 24759110 34 9318075 1 1
2024-03-18 8-K 8-K 2.02,9.01 0000950170-24-032826 001-40656 24759069 34 315968 1 1
2024-03-06 4 4 0000950170-24-027442 5482
2024-03-05 144 xsl144X01/primary_doc.xml 0001950047-24-001864 001-40656 24720875 33 5582
2024-02-27 4 4 0000950170-24-021550 8065
2024-02-27 4 4 0000950170-24-021548 8067
2024-02-27 4 4 0000950170-24-021547 7911
2024-02-27 4 4 0000950170-24-021546 8057
2024-02-21 4 4 0000950170-24-018222 7403
2024-02-20 144 xsl144X01/primary_doc.xml 0001950047-24-001143 001-40656 24654029 33 4836
2024-02-16 4 4 0000950170-24-016673 5539
2024-02-16 4 4 0000950170-24-016669 5676
2024-02-16 4 4 0000950170-24-016667 5521
2024-02-16 4 4 0000950170-24-016664 5527
2024-02-16 144 xsl144X01/primary_doc.xml 0000950170-24-016659 001-40656 24650324 33 4358
2024-02-16 144 xsl144X01/primary_doc.xml 0000950170-24-016656 001-40656 24650319 33 4195
2024-02-16 144 xsl144X01/primary_doc.xml 0000950170-24-016654 001-40656 24650299 33 4394
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-024006 005-92757 24640153 34 76967
2024-02-14 SC 13D/A SC 13D/A 0001193125-24-036263 005-92757 24638633 34 113514
2024-02-14 4 4 0000950170-24-015234 17570
2024-02-14 4 4 0000950170-24-015219 8628
2024-02-14 SC 13G/A tnya13gadec23.txt 0000080255-24-000760 005-92757 34 6539
2024-02-14 SC 13G/A TENAYA THERAPEUTICS, INC. 0000902664-24-001557 005-92757 24632290 34 62722
2024-02-08 424B5 424B5 0001193125-24-028514 333-266741 24610275 33 655683
2024-02-08 8-K 8-K 1.01,7.01,9.01 0001193125-24-027611 001-40656 24606946 34 508603 1 1
2024-01-31 S-8 S-8 0000950170-24-009388 333-276783 24583009 33 220396
2024-01-31 SC 13G us87990a1060_013124.txt 0001086364-24-006020 005-92757 24582140 34 13442
2023-11-08 10-Q 10-Q 0000950170-23-061162 001-40656 231388213 34 7984159 1 1
2023-11-08 8-K 8-K 2.02,9.01 0000950170-23-061123 001-40656 231387991 34 365959 1 1
2023-08-29 4 FORM 4 SUBMISSION 0001209191-23-047673 5628
2023-08-29 144 xsl144X01/primary_doc.xml 0001950047-23-003501 001-40656 231222263 33 4755
2023-08-18 4 FORM 4 SUBMISSION 0001209191-23-046642 5628
2023-08-18 4 FORM 4 SUBMISSION 0001209191-23-046641 5761
2023-08-18 4 FORM 4 SUBMISSION 0001209191-23-046640 5606
2023-08-18 4 FORM 4 SUBMISSION 0001209191-23-046639 5618
2023-08-16 144 xsl144X01/primary_doc.xml 0001288257-23-000003 001-40656 231179663 33 4195
2023-08-16 144 xsl144X01/primary_doc.xml 0001288257-23-000002 001-40656 231179659 33 4245
2023-08-09 10-Q 10-Q 0000950170-23-040651 001-40656 231155594 34 8620804 1 1
2023-08-09 8-K 8-K 2.02,9.01 0000950170-23-040628 001-40656 231155465 34 403806 1 1
2023-06-12 4 FORM 4 SUBMISSION 0001209191-23-036527 5704
2023-06-12 4 FORM 4 SUBMISSION 0001209191-23-036523 5712
2023-06-12 4 FORM 4 SUBMISSION 0001209191-23-036517 5706
2023-06-12 4 FORM 4 SUBMISSION 0001209191-23-036514 5734
2023-06-12 4 FORM 4 SUBMISSION 0001209191-23-036512 5682
2023-06-12 4 FORM 4 SUBMISSION 0001209191-23-036510 5695
2023-06-12 4 FORM 4 SUBMISSION 0001209191-23-036508 5715
2023-06-12 4 FORM 4 SUBMISSION 0001209191-23-036506 5673
2023-06-12 4 FORM 4 SUBMISSION 0001209191-23-036502 5685
2023-06-12 8-K 8-K 5.02,5.03,5.07,9.01 0000950170-23-027497 001-40656 231008352 34 562373 1 1
2023-05-10 10-Q 10-Q 0000950170-23-020609 001-40656 23907116 34 7661546 1 1
2023-05-10 8-K 8-K 2.02,9.01 0000950170-23-020588 001-40656 23906929 34 354818 1 1
2023-04-27 ARS ARS 0001193125-23-122238 001-40656 23857289 34 16453451
2023-04-27 DEFA14A DEFA14A 0001193125-23-122222 001-40656 23857217 34 324775
2023-04-27 DEF 14A DEF 14A 0001193125-23-122205 001-40656 23857119 34 893435
2023-04-17 PRE 14A PRE 14A 0001193125-23-103656 001-40656 23824148 34 812832
2023-03-21 8-K 8-K 5.03,9.01 0000950170-23-008934 001-40656 23749786 34 578467 1 1
2023-03-14 4 FORM 4 SUBMISSION 0000899243-23-008390 17954
2023-03-14 4 FORM 4 SUBMISSION 0000899243-23-008389 9253
2023-03-13 8-K 8-K 7.01 0000950170-23-007376 001-40656 23725042 34 185705 1 1
2023-03-08 S-8 S-8 0000950170-23-006732 333-270364 23716739 33 330376
2023-03-08 10-K 10-K 0000950170-23-006725 001-40656 23716597 34 21525982 1 1
2023-03-08 8-K 8-K 2.02,9.01 0000950170-23-006713 001-40656 23716266 34 393743 1 1
2023-02-21 SC 13D/A SC 13D/A 0001193125-23-043682 005-92757 23649563 34 115863
2023-02-17 4 FORM 4 SUBMISSION 0001209191-23-010887 10611
2023-02-17 4 FORM 4 SUBMISSION 0001209191-23-010884 10608
2023-02-17 4 FORM 4 SUBMISSION 0001209191-23-010881 10592
2023-02-17 4 FORM 4 SUBMISSION 0001209191-23-010880 8370
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021824 005-92757 23630742 34 81708
2023-02-14 SC 13G/A tnya13gadec22.txt 0000080255-23-002728 005-92757 34 6899
2023-02-10 4 FORM 4 SUBMISSION 0000899243-23-004584 17444
2023-02-10 4 FORM 4 SUBMISSION 0000899243-23-004580 8743
2023-02-09 SC 13G/A filing.txt 0000315066-23-002086 005-92757 23605118 34 8174
2023-01-23 4 FORM 4 SUBMISSION 0000899243-23-002382 17955
2023-01-23 4 FORM 4 SUBMISSION 0000899243-23-002377 9254
2023-01-19 4 FORM 4 SUBMISSION 0000899243-23-002161 20188
2023-01-19 4 FORM 4 SUBMISSION 0000899243-23-002158 11498
2022-12-09 4 FORM 4 SUBMISSION 0001209191-22-060596 5818
2022-12-07 4 FORM 4 SUBMISSION 0001209191-22-060234 5692
2022-12-07 3 FORM 3 SUBMISSION 0001209191-22-060232 4975
2022-12-07 8-K 8-K 5.02,9.01 0000950170-22-026162 001-40656 221450614 34 235380 1 1
2022-12-07 SC 13D/A d9882032_13d-a.htm 0000919574-22-006999 005-92757 221449909 34 117262
2022-12-01 SC 13D SC 13D 0001193125-22-296534 005-92757 221438973 34 141552
2022-11-28 SC 13D/A d9865568_13d-a.htm 0000919574-22-006912 005-92757 221425364 34 120054
2022-11-25 4 xslF345X03/ownership.xml 0000919574-22-006902 9828
2022-11-23 4 FORM 4 SUBMISSION 0000899243-22-036910 17449
2022-11-23 4 FORM 4 SUBMISSION 0000899243-22-036907 8749
2022-11-17 8-K 8-K 1.01,8.01,9.01 0001193125-22-287687 001-40656 221398699 34 515374 1 1
2022-11-17 424B5 424B5 0001193125-22-287677 333-266741 221398562 33 659372
2022-11-16 424B5 424B5 0001193125-22-286840 333-266741 221395861 33 663550
2022-11-10 10-Q 10-Q 0000950170-22-024521 001-40656 221377714 34 9078790 1 1
2022-11-10 8-K 8-K 2.02,9.01 0000950170-22-024496 001-40656 221377535 34 406633 1 1
2022-10-11 SC 13G/A filing.txt 0000315066-22-001789 005-92757 221302556 34 7969
2022-09-09 4 FORM 4 SUBMISSION 0001209191-22-049362 7643
2022-08-17 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-08-17 16:00:00 9999999995-22-002422 333-266741 221176239 33 1739
2022-08-17 424B5 424B5 0001193125-22-223273 333-266741 221174298 33 490826
2022-08-15 CORRESP filename1.htm 0001193125-22-221355 18049
2022-08-12 UPLOAD filename1.pdf 0000000000-22-008631 40244
2022-08-10 8-K 8-K 1.01,9.01 0001193125-22-217452 001-40656 221152524 34 434550 1 1
2022-08-10 S-3 S-3 0001193125-22-217445 333-266741 221152499 33 1169744
2022-08-10 10-Q 10-Q 0000950170-22-016478 001-40656 221152031 34 8297899 1 1
2022-08-10 8-K 8-K 2.02,9.01 0000950170-22-016457 001-40656 221151890 34 389293 1 1
2022-06-13 4 FORM 4 SUBMISSION 0001209191-22-036543 7658
2022-06-13 4 FORM 4 SUBMISSION 0001209191-22-036537 7680
2022-06-13 4 FORM 4 SUBMISSION 0001209191-22-036534 7696
2022-06-13 4 FORM 4 SUBMISSION 0001209191-22-036531 7639
2022-06-13 4 FORM 4 SUBMISSION 0001209191-22-036525 7670
2022-06-13 4 FORM 4 SUBMISSION 0001209191-22-036523 7627
2022-06-13 4 FORM 4 SUBMISSION 0001209191-22-036521 7640
2022-06-13 4 FORM 4 SUBMISSION 0001209191-22-036519 7678
2022-06-10 8-K 8-K 5.07 0000950170-22-011496 001-40656 221009504 34 198763 1 1
2022-05-11 10-Q 10-Q 0000950170-22-009363 001-40656 22914170 34 7238388 1 1
2022-05-11 8-K 8-K 2.02,9.01 0000950170-22-009350 001-40656 22913970 34 374777 1 1
2022-04-28 4 FORM 4 SUBMISSION 0001209191-22-026097 5386
2022-04-28 DEFA14A DEFA14A 0001193125-22-127776 001-40656 22867400 34 321277
2022-04-28 DEF 14A DEF 14A 0001193125-22-127693 001-40656 22867208 34 842281
2022-03-23 S-8 S-8 0001193125-22-082891 333-263802 22763965 33 96474
2022-03-23 10-K 10-K 0000950170-22-004426 001-40656 22763520 34 19583565 1 1
2022-03-23 8-K 8-K 2.02,9.01 0000950170-22-004414 001-40656 22763397 34 412871 1 1
2022-02-17 4 FORM 4 SUBMISSION 0001209191-22-010925 7817
2022-02-17 4 FORM 4 SUBMISSION 0001209191-22-010920 7680
2022-02-17 4 FORM 4 SUBMISSION 0001209191-22-010917 7832
2022-02-17 4 FORM 4 SUBMISSION 0001209191-22-010916 7825
2022-02-14 SC 13G SCHEDULE 13G, AMENDMENT 1 0001014108-22-000057 005-92757 22632036 34 59684
2022-02-14 SC 13G SCHEDULE 13G, AMENDMENT 1 0001014108-22-000052 005-92757 22631163 34 59605
2022-02-14 SC 13G SCHEDULE 13G 0001014108-22-000047 005-92757 22630839 34 60456
2022-02-14 SC 13G tnya13gdec21.txt 0000080255-22-002247 005-92757 34 6861
2022-02-14 SC 13G TENAYA THERAPEUTICS, INC. 0000902664-22-001622 005-92757 22626211 34 67586
2022-02-11 SC 13G SC 13G 0001193125-22-037190 005-92757 22621783 34 79127
2022-02-09 SC 13G/A filing.txt 0000315066-22-001231 005-92757 22604659 34 8425
2021-12-23 4 FORM 4 SUBMISSION 0001209191-21-071136 5481
2021-12-23 3 FORM 3 SUBMISSION 0001209191-21-071134 4942
2021-12-22 8-K 8-K 5.02,9.01 0001193125-21-365119 001-40656 211514155 34 174931 1 1
2021-11-22 4 FORM 4 SUBMISSION 0001209191-21-066224 5560
2021-11-22 3 FORM 3 SUBMISSION 0001209191-21-066222 4950
2021-11-22 8-K 8-K 5.02,9.01 0001193125-21-336078 001-40656 211430329 34 178728 1 1
2021-11-10 10-Q 10-Q 0001564590-21-056238 001-40656 211397339 34 11521283 1 1
2021-11-10 8-K 8-K 2.02,9.01 0001564590-21-056219 001-40656 211397060 34 486810 1 1
2021-09-08 10-Q 10-Q 0001564590-21-047363 001-40656 211242451 34 10893709 1 1
2021-09-08 8-K 8-K 2.02,9.01 0001193125-21-267844 001-40656 211242358 34 97028
2021-08-10 SC 13G filing.txt 0000315066-21-001677 005-92757 211158832 34 8430
2021-08-09 SC 13G SCHEDULE 13G 0001014108-21-000157 005-92757 211157409 34 52759
2021-08-09 SC 13G SC 13G 0001104659-21-102169 005-92757 211156982 34 87968
2021-08-09 SC 13D d8916845_13-d.htm 0000919574-21-004906 005-92757 211155923 34 128435
2021-08-04 4 FORM 4 SUBMISSION 0001209191-21-049769 25902
2021-08-04 4 FORM 4 SUBMISSION 0001209191-21-049765 22030
2021-08-04 4 FORM 4 SUBMISSION 0001209191-21-049763 16559
2021-08-04 4 FORM 4 SUBMISSION 0001209191-21-049762 22349
2021-08-04 4 FORM 4 SUBMISSION 0001209191-21-049759 7094
2021-08-03 8-K 8-K 5.03,7.01,9.01 0001193125-21-235079 001-40656 211140769 34 295636
2021-08-02 SEC STAFF LETTER filename1.pdf 9999999997-21-004411 271643
2021-07-30 S-8 S-8 0001193125-21-231682 333-258337 211133549 33 86584
2021-07-30 424B4 424B4 0001193125-21-231612 333-257820 211133232 33 14860491
2021-07-29 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-07-29 16:45:00 9999999995-21-002984 333-257820 211129874 33 1739
2021-07-29 S-1MEF S-1MEF 0001193125-21-229756 333-258285 211129788 33 67782
2021-07-29 3 FORM 3 SUBMISSION 0001209191-21-048709 16814
2021-07-29 3 FORM 3 SUBMISSION 0001209191-21-048701 8367
2021-07-29 3 FORM 3 SUBMISSION 0001209191-21-048700 5714
2021-07-29 3 FORM 3 SUBMISSION 0001209191-21-048699 7795
2021-07-29 3 FORM 3 SUBMISSION 0001209191-21-048698 9237
2021-07-29 3 FORM 3 SUBMISSION 0001209191-21-048695 7102
2021-07-29 3 FORM 3 SUBMISSION 0001209191-21-048693 7044
2021-07-29 3 FORM 3 SUBMISSION 0001209191-21-048692 15289
2021-07-29 3 FORM 3 SUBMISSION 0001209191-21-048691 7046
2021-07-29 3 FORM 3 SUBMISSION 0001209191-21-048690 10309
2021-07-29 3 FORM 3 SUBMISSION 0001209191-21-048689 13214
2021-07-29 3 FORM 3 SUBMISSION 0001209191-21-048553 6365
2021-07-29 3 FORM 3 SUBMISSION 0001209191-21-048549 8511
2021-07-29 3 FORM 3 SUBMISSION 0001209191-21-048543 10511
2021-07-27 CERT 8A_cert_TNYA.pdf 0001354457-21-000857 001-40656 211118337 34 734954
2021-07-27 CORRESP filename1.htm 0001193125-21-225763 12433
2021-07-27 CORRESP filename1.htm 0001193125-21-225733 21822
2021-07-26 CORRESP filename1.htm 0001193125-21-223567 21761
2021-07-26 S-1/A S-1/A 0001193125-21-223559 333-257820 211112262 33 16612529
2021-07-23 8-A12B 8-A12B 0001193125-21-223152 001-40656 211111670 34 13217
2021-07-15 UPLOAD filename1.pdf 0000000000-21-008755 44532
2021-07-09 CORRESP filename1.htm 0001193125-21-212012 30277
2021-07-09 S-1 S-1 0001193125-21-212010 333-257820 211083648 33 18756901
2021-06-24 UPLOAD filename1.pdf 0000000000-21-007818 48592
2021-06-16 DRS/A filename1.htm 0000950123-21-007898 377-04815 211020282 33 16367265
2021-06-15 DRSLTR filename1.htm 0000950123-21-007899 34142
2021-06-10 SEC STAFF LETTER filename1.pdf 9999999997-21-003343 272671
2021-06-03 UPLOAD filename1.pdf 0000000000-21-006925 50715
2021-05-07 DRS filename1.htm 0000950123-21-005602 377-04815 21904107 33 11406660

Latest XBRL company facts

One latest value per concept from companyfacts (203 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 227.93M 2026-10-29 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
dei EntityPublicFloat Entity Public Float USD 63.10M 2025-06-30 2025 FY 10-K 2026-03-11 0001193125-26-102252
ffd NetFeeAmt NetFeeAmt USD 665.28 2026-08-04 S-8 2026-08-05 0001193125-26-335231
ffd TtlFeeAmt TtlFeeAmt USD 665.28 2026-08-04 S-8 2026-08-05 0001193125-26-335231
ffd TtlOfferingAmt TtlOfferingAmt USD 4.82M 2026-08-04 S-8 2026-08-05 0001193125-26-335231
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-04 S-8 2026-08-05 0001193125-26-335231
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 3.66M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 573,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap AccruedIncomeTaxes Accrued Income Taxes USD 45,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 7.06M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 341,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 20.52M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 0 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 741.11M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 1.68M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 5.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 147.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 22.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap Assets Assets USD 76.68M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap AssetsCurrent Assets, Current USD 71.01M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 85,000 2024-09-30 2024 Q3 10-Q 2024-11-06 0000950170-24-122359
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 9,000 2024-09-30 2024 Q3 10-Q 2024-11-06 0000950170-24-122359
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 77.44M 2024-09-30 2024 Q3 10-Q 2024-11-06 0000950170-24-122359
us-gaap AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Remainder of Fiscal Year USD 39.60M 2023-09-30 2023 Q3 10-Q 2023-11-08 0000950170-23-061162
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 91.30M 2022-12-31 2022 FY 10-K 2023-03-08 0000950170-23-006725
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 77.52M 2024-09-30 2024 Q3 10-Q 2024-11-06 0000950170-24-122359
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-05 0001193125-26-335140
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 66.80M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 66.80M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 67.22M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 67.22M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -33.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 156.05M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 1.00B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 227.93M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 227.93M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap CommonStockValue Common Stock, Value, Issued USD 22,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -81.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 5.66M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 2.88M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 240.74M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-23 0000950170-22-004426
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 148.53M 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 2.40M 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 91.72M 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 152,000 2021-12-31 2022 FY 10-K 2023-03-08 0000950170-23-006725
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 21.93M 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 4.42M 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 1.22M 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 146.13M 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 419,000 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 3.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 3.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.37 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -1.44 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-10 0000950170-22-016478
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.37 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.213 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.02 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.019 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-10 0000950170-25-036329
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.027 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.01 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 1.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 300,000 2025-02-06 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD -61,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-23 0000950170-22-004426
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -89,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap GainLossOnTerminationOfLease Gain (Loss) on Termination of Lease USD -1.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 16.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -81.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 2.25M 2022-12-31 2023 FY 10-K 2024-03-18 0000950170-24-032828
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 19.29M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -19.02M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 70,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 1.76M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 938,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 286,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 388,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 8.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -2.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -434,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD -51,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 2.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap LeaseCost Lease, Cost USD 3.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.078 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 2.98M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 931,000 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 2.35M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 1.56M 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 628,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 123,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap Liabilities Liabilities USD 22.16M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 76.68M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap LiabilitiesCurrent Liabilities, Current USD 18.80M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap LongTermInvestments Long-term Investments USD 17.70M 2022-12-31 2023 FY 10-K 2024-03-18 0000950170-24-032828
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 114.96M 2022-09-30 2022 Q3 10-Q 2022-11-10 0000950170-22-024521
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 6.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -144,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -40.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -81.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 2.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap OperatingExpenses Operating Expenses USD 86.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -83.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap OperatingLeaseCost Operating Lease, Cost USD 2.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 1.20M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-11 0000950170-22-009363
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 2.85M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 2.42M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 432,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap OperatingLeasePayments Operating Lease, Payments USD 3.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 2.47M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 1.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 11.60M 2020-12-31 2021 FY 10-K 2022-03-23 0000950170-22-004426
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 2.21M 2020-12-31 2021 FY 10-K 2022-03-23 0000950170-22-004426
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 999,000 2020-12-31 2021 FY 10-K 2022-03-23 0000950170-22-004426
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 2.36M 2020-12-31 2021 FY 10-K 2022-03-23 0000950170-22-004426
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 2.28M 2020-12-31 2021 FY 10-K 2022-03-23 0000950170-22-004426
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 3.75M 2020-12-31 2021 FY 10-K 2022-03-23 0000950170-22-004426
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.091 2025-12-31 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap OtherAssetsCurrent Other Assets, Current USD 185,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 2.06M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD 1,000 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -28,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 160,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 52,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -1.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -3,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap PaymentsForProceedsFromOtherInvestingActivities Payments for (Proceeds from) Other Investing Activities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 13,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-08 0000950170-23-006725
us-gaap PaymentsOfDebtRestructuringCosts Payments of Debt Restructuring Costs USD 1.39M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-09-08 0001564590-21-047363
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 415,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 170,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 200.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 3.64M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 3.46M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 188.54M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-08 0000950170-23-006725
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 3.87M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-10 0000950170-25-036329
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 46.76M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-10 0000950170-25-036329
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 10.96M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-10 0001193125-25-273239
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 26,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 15,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-11 0000950170-22-009363
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 4.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -81.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 21.66M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 1.14M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 46.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 419,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -686.61M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 3.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 5.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.9 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.91 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.87 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.037 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.048 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.039 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 1.70M 2021-12-31 2021 FY 10-K 2022-03-23 0000950170-22-004426
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 4,400 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0.69 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap ShortTermInvestments Short-term Investments USD 57.12M 2024-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-06 0001193125-26-209084
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 54.52M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.167 2021-07-23 2022 FY 10-K 2023-03-08 0000950170-23-006725
us-gaap StockholdersEquityNoteSubscriptionsReceivable Stockholders' Equity Note, Subscriptions Receivable USD 87,000 2020-12-31 2021 FY 10-K 2022-03-23 0000950170-22-004426
us-gaap StockIssued1 Stock Issued USD 3,000 2024-01-01 2024-03-31 2025 Q1 10-Q 2025-05-07 0000950170-25-065741
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 8,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 43,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 2.37M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 29,000 2023-04-01 2023-06-30 2024 Q3 10-Q 2024-11-06 0000950170-24-122359
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 220.75M 2020-12-31 2021 FY 10-K 2022-03-23 0000950170-22-004426
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 227.90M 2020-12-31 2021 FY 10-K 2022-03-23 0000950170-22-004426
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2021-12-31 2021 FY 10-K 2022-03-23 0000950170-22-004426
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 0 2021-12-31 2021 FY 10-K 2022-03-23 0000950170-22-004426
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2021-12-31 2021 FY 10-K 2022-03-23 0000950170-22-004426
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2021-12-31 2021 FY 10-K 2022-03-23 0000950170-22-004426
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 7.26M 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 900,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 19.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001193125-26-102252
us-gaap VariableLeaseCost Variable Lease, Cost USD 1.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 220.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 41.29M 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-10 0000950170-22-016478
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 220.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447354

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →